Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Canopy Growth Corp T.WEED

Alternate Symbol(s):  T.WEED.DB | CGC

Canopy Growth Corporation is a cannabis company. It delivers innovative products with a focus on premium and mainstream cannabis brands, including Doja, 7ACRES, Tweed, and Deep Space, in addition to category-defining vaporizer technology made in Germany by Storz & Bickel. The principal activities of the Company are the production, distribution and sale of a diverse range of cannabis and cannabinoid-based products for both adult-use and medical purposes under a portfolio of distinct brands in Canada. Its Canada cannabis segment includes the production, distribution, and sale of a range of cannabis, hemp, and cannabis related products in Canada. International markets cannabis segment includes the production, distribution, and sale of a range of cannabis and hemp products internationally. Storz & Bickel segment includes the production, distribution, and sale of vaporizers. This Works segment includes the production, distribution and sale of beauty, skincare, wellness and sleep products.


TSX:WEED - Post by User

Bullboard Posts
Comment by dionsayson Apr 04, 2019 8:46pm
119 Views
Post# 29585239

RE:RE:RE:I hope Canopy gets announced as well or it doesnt look good

RE:RE:RE:I hope Canopy gets announced as well or it doesnt look goodIf Germany decides to legalize within the next two years, that would mean these companies would have to supply medical for 4 years?

"An official announcement of the much-anticipated winners of contracts to cultivate medical cannabis in Germany for a period of four years is expected soon from the Federal Institute for Drugs and Medical Devices (BfArM).
Read more at https://stockhouse.com/companies/bullboard?symbol=t.apha&postid=29583457#WOFiyurzYoIrCR1o.99"

Homestretch4me wrote: I dont think you understand. The companies selected to cultivate in Germany will have a distinct advantage in supplying all facets of that market. We are basically on the outside looking in. Stock price tomorrow will be reflective of Canopy's failure to secure a German cultivation contract.
krisruna wrote: The prices offered by Germany is extremely low ( i think around $ 4 per gram).  Canopy is getting $ 12 per gram from Germany now.  ACB also supplied Lexanberg for 2.5 Euro per gram. So, looks like ACB wants to supply (almost at any cost).

We can make lot more money in MJ derivates e.g. Softgels.




Bullboard Posts